RxDoctor Payments Data

Melissa Primrose, MD

Family Medicine · Gray, GANPI 1457496234

Payments from drug & device makers

$642in general payments, 2019–2025

Across 30 payments — averaging $21.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$218
  • Lilly USA, LLC$67
  • Johnson & Johnson$50
  • Inspire Medical Systems, Inc.$48
  • Pfizer$42
  • AstraZeneca$34
  • plus $184 from 10 others

What the payments were for

  • Food & beverage$62898%
  • Entertainment$142%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$642 in reported general payments places this provider in the 50th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$120,620
Medicare patients
303
Services billed
3,465

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide62$76,350
EliquisApixaban213$52,781
JanuviaSitagliptin Phosphate65$33,150
TrulicityDulaglutide38$32,779
JardianceEmpagliflozin38$30,384
ProliaDenosumab15$26,121
JanumetSitagliptin Phos/Metformin Hcl19$11,788
XareltoRivaroxaban37$11,559
RexultiBrexpiprazole18$10,288
MyrbetriqMirabegron35$10,109
EntrestoSacubitril/Valsartan13$8,754
Rosuvastatin Calcium682$5,464
Memantine Hcl395$5,389
Lantus SolostarInsulin Glargine,hum.Rec.Anlog55$4,635
Fluticasone-SalmeterolFluticasone Propion/Salmeterol13$3,779

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$218$76,35062 claims
PfizerEliquis$42$52,781213 claims
MerckJanuvia, Janumet$18$44,93884 claims
Lilly USA, LLCTrulicity$67$32,77938 claims
Johnson & JohnsonXarelto$50$11,55937 claims
Astellas Pharma US IncMyrbetriq$15$10,10935 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Gray

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →